LY404039 is an inhibitor for mGluR1 (Ki=149 nM) and mGluR2 (Ki= 92 nM), which can also inhibit dopamine receptor.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | LY404039 is a potent and selective mGluR2 and mGluR3 agonist with dissociation constants (Kis) of 149 nM for mGluR2 and 92 nM for mGluR3 in recombinant human receptors, exhibiting over 100-fold selectivity for these receptors over other receptors and transporters. LY404039 has demonstrated both antipsychotic and anxiolytic effects[1]. |
Animal study | LY404039 also mitigates amphetamine- and phencyclidine-induced hyperlocomotion at doses of 3-30 mg/kg and 10 mg/kg, respectively. At doses ranging from 3 to 10 mg/kg, it inhibits conditioned avoidance responding and reduces fear-potentiated startle in rats as well as marble burying in mice, underscoring its anxiolytic-like properties. At a dose of 10 mg/kg, it enhances dopamine and serotonin release/turnover in the prefrontal cortex[3].When administered orally to fasted rats at doses of 1, 3, or 10 mg/kg, LY404039 shows dose-proportional exposure increases. At a dose of 10 mg/kg, the peak plasma concentration (Cmax) reaches 1528.5 ng/mL with a peak time (Tmax) of 2 hours[1]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01609218 | Healthy Volunteer Study | Phase 1 | Completed | - | United Kingdom ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, West Yorkshire, United Kingdom, LS2 9LH 收起 << |
NCT01475136 | Hepatic Insufficiency | Phase 1 | Completed | - | Germany ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munich, Germany, 81241 Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Balatonfüred, Hungary, 8230 收起 << |
NCT01659177 | Healthy Participants | Phase 1 | Withdrawn(The decision to stop... 展开 >> the trial was based on efficacy results in the overall schizophrenia patient population.) 收起 << | September 2012 | Switzerland ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Allschwil, Switzerland, CH-4123 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
4.25mL 0.85mL 0.43mL |
21.26mL 4.25mL 2.13mL |
42.52mL 8.50mL 4.25mL |
CAS号 | 635318-11-5 |
分子式 | C7H9NO6S |
分子量 | 235.21 |
SMILES Code | O=C([C@]1(N)CS([C@@]2([H])[C@H](C(O)=O)[C@@]12[H])(=O)=O)O |
MDL No. | MFCD11974011 |
别名 | pomaglumetad |
运输 | 蓝冰 |
InChI Key | AVDUGNCTZRCAHH-MDASVERJSA-N |
Pubchem ID | 9834591 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place, sealed in dry, store in freezer, under -20°C |
溶解方案 |
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶。
|